FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals’ Brilacidin for …,

WAKEFIELD, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB: IPIX) (“the Company”), a clinical stage …, WAKEFIELD, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB: IPIX) (“the Company”), a clinical stage …, Read More

Scroll to Top